Mental disorders represent a worldwide public health concern. Psychotherapies and
pharmacotherapies are recommended as first line treatments. However, evidence has …

Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …

Background Psilocybin has been suggested as a novel, rapid-acting treatment for
depression. Two consecutive doses have been shown to markedly decrease symptom …

Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …

Importance Depression is common and associated with substantial burden. Suicide rates
have increased over the past decade, and both suicide attempts and deaths have …

Forest therapy involves engaging in a combination of forest-based activities to improve one's
health or wellbeing. We conducted an overview of systematic reviews (SRs) and meta …

The theory that depression is caused by a serotonin abnormality or other chemical
imbalance has become widely accepted by the public and is one prominent justification for …

Statement of Retraction Retraction: Anatomy of a Woebot®(WB001): Agent Guided CBT for
women with postpartum depression We, the Editor and Publisher of Expert Review of …

Quantifying neural activity in natural conditions (ie conditions comparable to the standard
clinical patient experience) during the administration of psychedelics may further our …

Brain imaging techniques enable the visualization of serotonin transporter (SERT)
occupancy as a measure of the proportion of SERT blocked by an antidepressant at a given …